The Cost Effectiveness of Tacrolimus versus Microemulsified Cyclosporin
- 1 January 2003
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 21 (17) , 1263-1276
- https://doi.org/10.2165/00019053-200321170-00003
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Tacrolimus versus ciclosporin immunosuppression: long-term outcome in renal transplantationNephrology Dialysis Transplantation, 2003
- Modeling for Health Care and Other Policy Decisions: Uses, Roles, and ValidityValue in Health, 2001
- CyclosporinDrugs, 2001
- Handling Uncertainty in Cost-Effectiveness ModelsPharmacoEconomics, 2000
- HEALTH-RELATED QUALITY OF LIFE AMONG RENAL-TRANSPLANT RECIPIENTS IN JAPAN1Transplantation, 1999
- Cyclosporine and tacrolimus (FK506): A comparison of efficacy and safety profilesClinical Transplantation, 1999
- The economics of immunosuppression in renal transplantation: a review of recent literatureTransplantation Proceedings, 1999
- Tacrolimus and cyclosporine efficacy in high-risk kidney transplantation on behalf of the European Multicentre Tacrolimus (FK506) Renal Study GroupTransplant International, 1998
- ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN KIDNEY TRANSPLANT PATIENTS RECEIVING TACROLIMUS (FK506)-BASED VERSUS CYCLOSPORINE-BASED IMMUNOSUPPRESSION1,2Transplantation, 1997
- A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1997